Valuation: TELES

Market Cap 1.27M 1.47M 1.19M 1.09M 2.06M 140M 2.08M 13.93M 5.47M 69.74M 5.5M 5.38M 232M P/E 2024
-4.29x
P/E 2025 -4.4x
Enterprise Value 4.97M 5.72M 4.65M 4.25M 8.03M 545M 8.14M 54.4M 21.35M 272M 21.49M 21.02M 907M EV / Sales 2024
19.8x
EV / Sales 2025 90.1x
Free-Float
26.91%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2023-12-31
Director TitleAgeSince
Chairman - -
Director/Board Member - 2019-08-11
Director/Board Member - 2019-08-11
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.47M
-0.36%-2.02%-3.74%+27.16% 232B
+0.53%+1.50%+10.51%+43.87% 193B
+6.31%+7.56%-6.90%+55.15% 152B
-0.98%-4.81%-24.04%+15.78% 79.77B
+2.32%-3.62%+0.13%-2.52% 78.06B
-3.21%-4.76%+22.51%+22.22% 72.48B
-0.46%+2.50%+2.36%+4.53% 57.9B
-0.46%-6.07%+8.52%+77.46% 55.43B
-0.10%+5.53%+10.07%-5.07% 49.72B
Average +0.28%-1.74%+2.16%+26.51% 107.81B
Weighted average by Cap. +0.68%-1.80%+0.98%+31.05%

Financials

2024 2025
Net sales 207K 239K 194K 177K 335K 22.73M 339K 2.27M 890K 11.36M 896K 877K 37.81M 68.54K 78.98K 64.18K 58.71K 111K 7.52M 112K 751K 295K 3.76M 297K 290K 12.51M
Net income -836K -963K -782K -716K -1.35M -91.72M -1.37M -9.15M -3.59M -45.83M -3.62M -3.54M -153M -564K -650K -528K -483K -912K -61.89M -924K -6.18M -2.42M -30.92M -2.44M -2.39M -103M
Net Debt 510K 588K 478K 437K 825K 56.02M 836K 5.59M 2.19M 27.99M 2.21M 2.16M 93.16M 3.69M 4.26M 3.46M 3.16M 5.97M 406M 6.05M 40.47M 15.88M 203M 15.99M 15.64M 674M
Logo TELES
Arzneiwerk VIDA AG, formerly Teles AG, is a Germany-based financial holding company. The Company is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. It focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.
Employees
-